abstract |
The present invention relates to novel bis-pyridylpyridones that are antagonists of melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, methods of preparing them, and for their treatment in the treatment of obesity and diabetes Provide the use of. |